The EQUITY Coalition Responds to Governor Newsom’s May Budget Revise

Proposed budget falls short of addressing urgent gaps in health data sharing despite $97.5 billion budget surplus SACRAMENTO, Calif.–(BUSINESS WIRE)–The data sharing EQUITY Coalition, made up of more than 25 health plans, provider groups, and health information organizations, released the following statement in response to Governor Newsom’s May Revision to the CA 2022-23 budget proposal: … [Read more…]

Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting

Emendo Biotherapeutics revealed pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, generating a highly specific editing composition that achieves both no off-targets and complete allele specificity, in oral presentation at ASGCT annual meeting by Emendo Executive VP R&D Rafi Emmanuel, Ph.D. Emendo also presented three posters at ASGCT, … [Read more…]

Phreesia’s Danielle Lynch Named a ‘Sales MVP’ in PM360’s ELITE 100

RALEIGH, N.C.–(BUSINESS WIRE)–Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named Danielle Lynch, Vice President, Client Experience, as one of the 2022 PM360 ELITE 100. The PM360 ELITE Awards recognize the most influential people in the healthcare and life sciences industry today, and honorees were chosen from a pool … [Read more…]

Optime Care Launches First-in-Class, Novel Copay Assistance Program, Uses Block-Chain Technology to Address Drug Manufacturer Partners’ Challenges

EARTH CITY, Mo.–(BUSINESS WIRE)–#CopayAdvisor—Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces the launch of Copay AdvisorSM, a first-in-class, innovative copay assistance program to proactively address challenges and unmet needs of its drug manufacturer partners. Utilizing proprietary block-chain technology as … [Read more…]

USOSM Selects Sowingo as Its Clinical Supply Procurement and Inventory Management Platform

TORONTO–(BUSINESS WIRE)–Sowingo, North America’s leading cloud-based dental procurement and inventory management company, has been selected by U.S. Oral Surgery Management (USOSM) – a specialty management services company that exclusively serves premier oral and maxillofacial surgeons – as its clinical supply procurement and inventory management platform. USOSM, a market leader in oral surgery management that has … [Read more…]

Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods

TOKYO–(BUSINESS WIRE)–Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium longum BB536 was approved by the National Health Commission (NHC) of the People’s Republic of China as a new food ingredient for use in infant and toddler foods (under the age of three) on 11th May … [Read more…]

New Research Shows Patient Proximity to Primary Care, Pharmacies Linked With Mental and Overall Health Satisfaction

RedBox Rx Conducts Study in Honor of Mental Health Awareness Month DES MOINES, Iowa–(BUSINESS WIRE)–Americans who live farther from a primary care provider or pharmacy are more likely to be dissatisfied with their mental and overall health, according to a new study conducted by Morning Consult for RedBox Rx, a telehealth and online pharmacy provider. … [Read more…]

India $200+ Million Sleep Apnea Devices Markets, Analysis, Competition, Forecast & Opportunities, 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “India Sleep Apnea Devices Market Report 2022” has been added to ResearchAndMarkets.com’s offering. The Indian Sleep Apnea Devices Market is anticipated to grow from USD120.81 million in 2021 to USD200.93 million in 2027 at a CAGR of 8.47% in the forecast period. Growing health-consciousness among consumers about the benefits of adopting preventive healthcare … [Read more…]

Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2022

Fast Track and Orphan Drug Designation for PXL065 and PXL770 in adrenoleukodystrophy (ALD) granted by the Food and Drug Administration (FDA) Phase 2 study results for PXL065 (DESTINY-1) in NASH expected in Q3 2022 As of March 31, 2022, cash and cash equivalents were EUR 24.0 million (USD 26.7 million) LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext … [Read more…]

Global Head and Neck Cancer Therapeutics Market Report 2022: Diagnostic Methods v/s Treatment Type – Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of Administration, By Therapeutic Class), By End User, By Region, Company, Opportunities and Forecast, 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Head and Neck Cancer Therapeutics Market value … [Read more…]